IL58489A0 - The production of oxymorphone - Google Patents

The production of oxymorphone

Info

Publication number
IL58489A0
IL58489A0 IL58489A IL5848979A IL58489A0 IL 58489 A0 IL58489 A0 IL 58489A0 IL 58489 A IL58489 A IL 58489A IL 5848979 A IL5848979 A IL 5848979A IL 58489 A0 IL58489 A0 IL 58489A0
Authority
IL
Israel
Prior art keywords
oxymorphone
production
Prior art date
Application number
IL58489A
Other languages
English (en)
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of IL58489A0 publication Critical patent/IL58489A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polarising Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL58489A 1978-10-19 1979-10-18 The production of oxymorphone IL58489A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19

Publications (1)

Publication Number Publication Date
IL58489A0 true IL58489A0 (en) 1980-01-31

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58489A IL58489A0 (en) 1978-10-19 1979-10-18 The production of oxymorphone

Country Status (16)

Country Link
JP (1) JPS55501025A (cs)
AU (1) AU5189779A (cs)
BE (1) BE879494A (cs)
CA (1) CA1108132A (cs)
CS (1) CS211364B2 (cs)
DK (1) DK258280A (cs)
ES (1) ES485154A1 (cs)
FI (1) FI793235A7 (cs)
FR (1) FR2439201A1 (cs)
GB (1) GB2049680A (cs)
IL (1) IL58489A0 (cs)
IT (1) IT7969032A0 (cs)
NL (1) NL7920126A (cs)
NO (1) NO793297L (cs)
SE (1) SE8004454L (cs)
WO (1) WO1980000841A1 (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (fr) * 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
DE69033035T2 (de) * 1989-10-16 1999-08-05 The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C. Totale synthese von northebain-, normorphin-, noroxymorphon-enantiomeren und -derivaten via n-nor-zwischenverbindungen
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
KR20030034171A (ko) 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
DK1404331T3 (da) 2001-07-06 2008-01-28 Penwest Pharmaceuticals Co Sustained release-formuleringer af oxymorphon
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5695296B2 (ja) 2006-03-02 2015-04-01 マリンクロッド エルエルシー 低レベルのアルファ,ベータ−不飽和ケトン化合物を伴うモルフィナン−6−オン生成物の製造方法
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
ES2599031T3 (es) 2008-05-09 2017-01-31 Grünenthal GmbH Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización
BR112012001466A2 (pt) 2009-07-22 2020-08-11 Grünenthal GmbH forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem
ES2534908T3 (es) 2009-07-22 2015-04-30 Grünenthal GmbH Forma de dosificación de liberación controlada extruida por fusión en caliente
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
WO2012028318A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer
JP6063462B2 (ja) 2011-07-29 2017-01-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
BR112014019988A8 (pt) 2012-02-28 2017-07-11 Gruenenthal Gmbh Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico
LT2838512T (lt) 2012-04-18 2018-11-12 Grünenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
HK1224189A1 (zh) 2013-11-26 2017-08-18 Grünenthal GmbH 通过低温研磨制备粉状药物组合物
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
EP3252055B1 (en) 2016-05-31 2018-09-19 Alcaliber Investigacion Desarrollo e Innovacion SLU Process for obtaining 3,14-diacetyloxymorphone from oripavine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
NL7920126A (nl) 1980-08-29
NO793297L (no) 1980-04-22
CS211364B2 (en) 1982-02-26
DK258280A (da) 1980-06-17
SE8004454L (sv) 1980-06-16
BE879494A (fr) 1980-02-15
IT7969032A0 (it) 1979-10-18
JPS55501025A (cs) 1980-11-27
ES485154A1 (es) 1980-06-16
CA1108132A (en) 1981-09-01
FI793235A7 (fi) 1981-01-01
FR2439201A1 (fr) 1980-05-16
WO1980000841A1 (en) 1980-05-01
GB2049680A (en) 1980-12-31
AU5189779A (en) 1980-04-24

Similar Documents

Publication Publication Date Title
GB2017101B (en) Production of maytansinoids
JPS54105273A (en) Production of riceecracker
JPS5523999A (en) Production of 66aminoo 66deoxyyllsolbose
JPS54109932A (en) Manufacture of fluorobenzol
GB2015992B (en) Manufacture of para-nitro-diphenylamines
JPS54132575A (en) Manufacture of tetrahydrobenzoxocin
GB2012276B (en) Producing cephalosporins
GB2015997B (en) Production of nitrodiarylamines
GB2022083B (en) Production of iso-alpha-acids
JPS54109924A (en) Manufacture of silylphosphate
JPS54163538A (en) Production of salycilaldehydes
GB2015427B (en) Production of laminates
IL56245A0 (en) 8-alkyl-substituted morphinan-6-one compounds and their production
JPS54100322A (en) Manufacture of nnacyltaurine
JPS54131600A (en) Manufacture of borazin
JPS54122243A (en) Manufacture of 22nitrobenzaldehyde
JPS54135737A (en) Manufacture of trifluoromethylphenols
IL58568A (en) Manufacture of 5-cyano-4-methyloxazole
IL58941A (en) Production of phenyl-2-fluoroacrylate
JPS54143495A (en) Production of polyvinylpyrolidoneeiodine
JPS54128530A (en) Manufacture of ppaminoodiphenylamine
IL57174A (en) Manufacture of alpha-chloroacetoacetamides
GB2014178B (en) Halogenoantyraquinone compounds and the production and usethereof
JPS54112858A (en) Manufacture of 22pyrrolidone
JPS54117412A (en) Manufacture of 22nitroo22methyll11propanol